Federal Register Notice: FDA will hold a public meeting 6/23 entitled “Ultra High Throughput Sequencing for Clinical Diagnostic Applications — Approaches to Assess Analytical Validity.” Its purpose is to discuss challenges in assessing analytical performance for ultra high throughput genomic sequencing- based clinical applications. The meeting will be held from 8 a.m. to 6 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503 (the Great Room), Silver Spring, MD. The public meeting will also be available to be viewed online via Web cast. Contact Zivana Tezak, (301) 796-6206. To view this notice, click here.